Loading company…
Optherion develops diagnostics and disease-modifying treatments for early-stage age-related macular degeneration.
Optherion is a biotechnology company developing diagnostic and disease-modifying therapies for managing and treating early-stage age-related macular degeneration.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in